Keyphrases
Telomere Dysfunction
100%
POT1
100%
Clonal Hematopoiesis
100%
Mutation Carriers
85%
Telomere Length
57%
Non-carriers
42%
Telomere Shortening
28%
Telomere
28%
Aging
14%
Clinical Features
14%
B-cell Lymphoma
14%
Inheritance Pattern
14%
Autosomal Dominant
14%
Penetrance
14%
Early Disease
14%
Age-related Illnesses
14%
Dominant Pattern
14%
Janus Kinase 2 (JAK2)
14%
T-cell Lymphoma
14%
Gain-of-function mutation
14%
Malignant Neoplasms
14%
Molecular Features
14%
Neural Tissue
14%
Mesenchymal Tissue
14%
Validation Cohort
14%
Solid Neoplasms
14%
First Decade
14%
Aging Mechanism
14%
Genetic Anticipation
14%
Successive Generations
14%
Benign Neoplasm
14%
Epithelial Tissue
14%
Epithelial-mesenchymal
14%
Lymphoma Cancer
14%
Telomerase Gene
14%
99th Percentile
14%
Additional mutations
14%
T-cell Clonality
14%
DNMT3A
14%
Cellular Aging
14%
Driver mutations
14%
Hotspot mutation
14%
Cellular Lifespan
14%
Myeloid Cancer
14%
Mutation Burden
14%
Short Telomere Syndromes
14%
Clonal Hematopoiesis of Indeterminate Potential
14%
Biochemistry, Genetics and Molecular Biology
Telomere
100%
Hematopoiesis
100%
POT1
100%
Telomere Length
57%
Telomere Shortening
28%
T Cell
28%
B Cell
14%
Genetic Susceptibility
14%
Autosomal Dominant Inheritance
14%
Penetrance
14%
Myeloid
14%
Loss of Function Mutation
14%
Clonality
14%
Clonal Variation
14%
Janus Kinase
14%
Cell Aging
14%
DNMT3A
14%